We advised the debt and preferred equity financing sources on the transaction

Davis Polk advised a number of debt and equity financing sources whose funds were used to finance the acquisition of a healthcare software company by an investor group of leading private equity firms. Our clients included the administrative and collateral agent and several other banks as joint lead arrangers and bookrunners on a $5.9 billion senior secured term loan facility, a $1 billion senior secured delayed draw term facility and a $1 billion senior secured revolving credit facility. We also advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering of $2.35 billion aggregate principal amount of the company’s 6.500% senior notes due 2030 and the investors in the purchase of $2.35 billion of preferred stock issued by the company.

The Davis Polk finance team included partners James A. Florack, Jason Kyrwood, Kenneth J. Steinberg and Nicholas A. Palumbo, counsel Randy Dorf and associates Adela Troconis, Esam Ibrahim, and Jason Palios. All members of the Davis Polk team are based in the New York office.

Copy link to share post